Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/UroGen Pharma Ltd./ 10-K

Annual Report · 10-K

UroGen Pharma Ltd.

URGNNASDAQEQUITYCurrent

Annual Report

Filed Mar 24, 2023Accepted Mar 24, 2023, 8:17 AM EDTCIK 1668243Accession 0001437749-23-007710
View company →Permanent SEC source ↗
Share

Company context

Current securities

URGNNASDAQ · EQUITY · Current

Recent company filings

  1. 144 filingSep 9, 2026
  2. 4 filingAug 28, 2026
  3. Other EventsAug 20, 2026
  4. 10-Q filingAug 5, 2026
  5. Results of Operations and Financial ConditionAug 5, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗